Tag: clinical study

InnoCare Pharma, ArriVent BioPharma initiate Phase 1b clinical trial in NSCLC

businessnewstoday- April 1, 2024 0

InnoCare Pharma, listed on both the Hong Kong Stock Exchange (HKEX: 09969) and the Shanghai Stock Exchange (SSE: 688428), along with ArriVent BioPharma, Inc. (Nasdaq: ... Read More